Florence M. Muller, Elizabeth J. Li, Margaret E. Daube-Witherspoon, Austin R. Pantel, Corinde E. Wiers, Jacob G. Dubroff, Christian Vanhove, Stefaan Vandenberghe, Joel S. Karp
{"title":"Impact of deep learning denoising on kinetic modelling for low-dose dynamic PET: application to single- and dual-tracer imaging protocols","authors":"Florence M. Muller, Elizabeth J. Li, Margaret E. Daube-Witherspoon, Austin R. Pantel, Corinde E. Wiers, Jacob G. Dubroff, Christian Vanhove, Stefaan Vandenberghe, Joel S. Karp","doi":"10.1007/s00259-025-07182-6","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Long-axial field-of-view PET scanners capture multi-organ tracer distribution with high sensitivity, enabling lower dose dynamic protocols and dual-tracer imaging for comprehensive disease characterization. However, reducing dose may compromise data quality and time-activity curve (TAC) fitting, leading to higher bias in kinetic parameters. Parametric imaging poses further challenges due to noise amplification in voxel-based modelling. We explore the potential of deep learning denoising (DL-DN) to improve quantification for low-dose dynamic PET.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Using 16 [<sup>18</sup>F]FDG PET studies from the PennPET Explorer, we trained a DL framework on 10-min images from late-phase uptake (static data) that were sub-sampled from 1/2 to 1/300 of the counts. This model was used to denoise early-to-late dynamic frame images. Its impact on quantification was evaluated using compartmental modelling and voxel-based graphical analysis for parametric imaging for single- and dual-tracer dynamic studies with [<sup>18</sup>F]FDG and [<sup>18</sup>F]FGln at original (injected) and reduced (sub-sampled) doses. Quantification differences were evaluated for the area under the curve of TACs, K<sub>i</sub> for [<sup>18</sup>F]FDG and V<sub>T</sub> for [<sup>18</sup>F]FGln, and parametric images.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>DL-DN consistently improved image quality across all dynamic frames, systematically enhancing TAC consistency and reducing tissue-dependent bias and variability in K<sub>i</sub> and V<sub>T</sub> down to 40 MBq doses. DL-DN preserved tumor heterogeneity in Logan V<sub>T</sub> images and delineation of high-flux regions in Patlak K<sub>i</sub> maps. In a /[<sup>18</sup>F]FDG dual-tracer study, bias trends aligned with single-tracer results but showed reduced accuracy for [¹⁸F]FGln in breast lesions at very low doses (4 MBq).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>This study demonstrates that applying DL-DN trained on static [<sup>18</sup>F]FDG PET images to dynamic [<sup>18</sup>F]FDG and [<sup>18</sup>F]FGln PET can permit significantly reduced doses, preserving accurate FDG K<sub>i</sub> and FGln V<sub>T</sub> measurements, and enhancing parametric image quality. DL-DN shows promise for improving dynamic PET quantification at reduced doses, including novel dual-tracer studies.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"54 1","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07182-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Long-axial field-of-view PET scanners capture multi-organ tracer distribution with high sensitivity, enabling lower dose dynamic protocols and dual-tracer imaging for comprehensive disease characterization. However, reducing dose may compromise data quality and time-activity curve (TAC) fitting, leading to higher bias in kinetic parameters. Parametric imaging poses further challenges due to noise amplification in voxel-based modelling. We explore the potential of deep learning denoising (DL-DN) to improve quantification for low-dose dynamic PET.
Methods
Using 16 [18F]FDG PET studies from the PennPET Explorer, we trained a DL framework on 10-min images from late-phase uptake (static data) that were sub-sampled from 1/2 to 1/300 of the counts. This model was used to denoise early-to-late dynamic frame images. Its impact on quantification was evaluated using compartmental modelling and voxel-based graphical analysis for parametric imaging for single- and dual-tracer dynamic studies with [18F]FDG and [18F]FGln at original (injected) and reduced (sub-sampled) doses. Quantification differences were evaluated for the area under the curve of TACs, Ki for [18F]FDG and VT for [18F]FGln, and parametric images.
Results
DL-DN consistently improved image quality across all dynamic frames, systematically enhancing TAC consistency and reducing tissue-dependent bias and variability in Ki and VT down to 40 MBq doses. DL-DN preserved tumor heterogeneity in Logan VT images and delineation of high-flux regions in Patlak Ki maps. In a /[18F]FDG dual-tracer study, bias trends aligned with single-tracer results but showed reduced accuracy for [¹⁸F]FGln in breast lesions at very low doses (4 MBq).
Conclusion
This study demonstrates that applying DL-DN trained on static [18F]FDG PET images to dynamic [18F]FDG and [18F]FGln PET can permit significantly reduced doses, preserving accurate FDG Ki and FGln VT measurements, and enhancing parametric image quality. DL-DN shows promise for improving dynamic PET quantification at reduced doses, including novel dual-tracer studies.
期刊介绍:
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.